Prot# MSLT-II: Multicenter Selective Lymphadenectomy Trial II (MSLT-II): A Phase III Multicenter Randomized trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Mol

Project: Research project

Project Details

Effective start/end date11/1/089/29/09


  • John Wayne Cancer Institute (MSLT-II // 1 P01 CA029605)
  • National Cancer Institute (MSLT-II // 1 P01 CA029605)